HSTC Stock Overview
Operates as an integrated health and wellness biotechnology company in the United States. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 2/6 |
| Dividends | 0/6 |
HST Global, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$0.31 |
| 52 Week High | US$1.15 |
| 52 Week Low | US$0.23 |
| Beta | -0.73 |
| 11 Month Change | -70.38% |
| 3 Month Change | -70.67% |
| 1 Year Change | -38.40% |
| 33 Year Change | 156.67% |
| 5 Year Change | 92.50% |
| Change since IPO | -99.82% |
Recent News & Updates
Recent updates
Shareholder Returns
| HSTC | US Biotechs | US Market | |
|---|---|---|---|
| 7D | -41.9% | 2.5% | 2.2% |
| 1Y | -38.4% | 16.1% | 31.6% |
Return vs Industry: HSTC underperformed the US Biotechs industry which returned 16.2% over the past year.
Return vs Market: HSTC underperformed the US Market which returned 31.7% over the past year.
Price Volatility
| HSTC volatility | |
|---|---|
| HSTC Average Weekly Movement | n/a |
| Biotechs Industry Average Movement | 9.8% |
| Market Average Movement | 6.3% |
| 10% most volatile stocks in US Market | 15.7% |
| 10% least volatile stocks in US Market | 3.1% |
Stable Share Price: HSTC's share price has been volatile over the past 3 months compared to the US market.
Volatility Over Time: Insufficient data to determine HSTC's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| n/a | n/a | n/a | www.hstglobal.com |
HST Global, Inc., operates as an integrated health and wellness biotechnology company in the United States. The company develops and/or acquires a network of wellness centers for the homeopathic and alternative treatment of late stage cancer and other life threatening diseases. It also focuses on the homeopathic and alternative product candidates that are undergoing or have already completed clinical testing for the treatment of late stage cancer and or/ life threatening diseases.
HST Global, Inc. Fundamentals Summary
| HSTC fundamental statistics | |
|---|---|
| Market cap | US$14.71m |
| Earnings (TTM) | -US$101.51k |
| Revenue (TTM) | n/a |
0.0x
P/S Ratio-145.0x
P/E RatioIs HSTC overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| HSTC income statement (TTM) | |
|---|---|
| Revenue | US$0 |
| Cost of Revenue | US$0 |
| Gross Profit | US$0 |
| Other Expenses | US$101.51k |
| Earnings | -US$101.51k |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.0021 |
| Gross Margin | 0.00% |
| Net Profit Margin | 0.00% |
| Debt/Equity Ratio | 3.4% |
How did HSTC perform over the long term?
See historical performance and comparison